You are viewing an incomplete version of our website. Please click to reload the website as full version.

Interleukin-1 Receptor-Associated Kinase 2 (IRAK2) (C-Term) Peptide

Details for Product No. ABIN1382040, Supplier: Log in to see
Protein Name
  • IRAK-2
  • 6330415L08Rik
  • AI649099
Protein Region
C-Term
Origin
Human
4
3
Application
Blocking Peptide (BP)
Supplier
Log in to see
Supplier Product No.
Log in to see
Request

Showcase your results, aid the scientific community, and receive a full refund.

Contribute a validation

Learn more

Blocked Antibody anti-IRAK2 antibody (Interleukin-1 Receptor-Associated Kinase 2) (C-Term) (ABIN1030444)
Characteristics 20 amino acids near the carboxy terminus of human IRAK2.
Human
Research Area Immunology, Innate Immunity, Cytokines, Receptors, Inflammation
Application Notes IRAK2 peptide is used for blocking the activity of IRAK2.
Restrictions For Research Use only
Format Liquid
Concentration 200 μg/mL
Buffer PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1 % bovine serum albumin and 0.02 % sodium azide
Preservative Sodium azide
Precaution of Use This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage -20 °C
Expiry Date 12 months
Background publications Muzio, Ni, Feng et al.: "IRAK (Pelle) family member IRAK-2 and MyD88 as proximal mediators of IL-1 signaling." in: Science (New York, N.Y.), Vol. 278, Issue 5343, pp. 1612-5, 1997 (PubMed).

Degli-Esposti, Smolak, Walczak et al.: "Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family." in: The Journal of experimental medicine, Vol. 186, Issue 7, pp. 1165-70, 1997 (PubMed).

Sheridan, Marsters, Pitti et al.: "Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors." in: Science (New York, N.Y.), Vol. 277, Issue 5327, pp. 818-21, 1997 (PubMed).